How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Vabysmo cost savings if eligible
The Vabysmo patient assistance program can provide your medication for free. We simply charge $49 per month for each medication to cover the cost of our services. With NiceRx, you will only pay $49 to obtain your Vabysmo, regardless of the retail price.
Am I eligible for the Vabysmo patient assistance program?
To find out if you are eligible for Vabysmo assistance you can apply online using our enrollment application. Each pharmaceutical company sets its eligibility criteria, and we will review your application individually to determine if you may be eligible. The three main factors to consider are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Vabysmo patient assistance program?
Our application process aims to make it as easy as possible to apply for the Vabysmo patient assistance program. The first step is to complete our online enrollment application. We will ask you for details about your healthcare provider, your insurance plan, and your household income as this information is required by the pharmaceutical companies. We may be able to help you apply for other patient assistance programs too, so be sure to tell us about any medications you are taking as well as Vabysmo.
NiceRx will review your application and determine whether you may be eligible for Vabysmo assistance. If so, we will handle the full enrollment process for you and prepare all required documents for your healthcare provider to sign. Once you are successfully enrolled in the Vabysmo patient assistance program, we will help you manage your prescription refills by requesting refills on your behalf throughout your enrollment period. At the end of your enrollment period, we will contact you for updated information and seek to re-enroll you so you can continue to access affordable Vabysmo.
Is NiceRx a Vabysmo coupon provider?
NiceRx is a service provider that helps eligible individuals access the Vabysmo patient assistance program. We do not offer trial offers or free Vabysmo samples. When obtaining your medication through NiceRx, you will only pay $49 a month per medication. This will likely save you more money than if you were to use Vabysmo coupons, discount cards, or Vabysmo copay cards.
Can NiceRx help me get Vabysmo cheaper if I have insurance?
NiceRx may be able to help you if your insurance company will not pay for your Vabysmo medication. We may also be able to help if you have a high copay or coinsurance responsibility. Whether you have insurance or not, apply online using our enrollment application to find out more.
How much does Vabysmo cost without insurance?
Vabysmo prices without insurance will vary depending on how much you buy. Prices will also vary by retailer. As a guide, Vabysmo typically costs $2,200 per treatment.
How much does Vabysmo cost with insurance?
The copay for Vabysmo will vary by the terms of your healthcare plan. To find out what you might need to pay for Vabysmo with insurance, your insurance provider or pharmacist will be able to help you calculate the copay costs with your current insurance.
What is Vabysmo?
Vabysmo, the first bispecific antibody for the eye, is a vascular endothelial growth factor A (VEGF-A) and angiopoietin-2 (Ang-2) inhibitor indicated for the treatment of patients with, Neovascular wet Age-Related Macular Degeneration, wet AMD (when abnormal blood vessels grow under the retina), and Diabetic Macular Edema (DME).
Vabysmo is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Genentech a subsidiary of the Roche group. FDA Approval of Vabysmo was based on findings from four studies. In the Avonelle-X study, an extension of the Tenaya and Lucerne studies, patients with AMD were randomized to receive the study drug or aflibercept. In the Rhone-X study, an extension of the Yosemite and Rhine studies, patients with DME were randomized to receive aflibercept every 8 weeks or the same-dose Vabysmo every 8 weeks or every 4 weeks. The primary endpoint was a change in visual acuity from baseline at 1 year. Findings from these studies showed that Vabysmo was non-inferior to aflibercept.
What doses of Vabysmo are available?
Vabysmo is available in injection form, in the following doses: 120 mg/mL solution in a single-dose vial.
Please read the full prescribing information and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Vabysmo active ingredients
Vabysmo contains faricimab-svoa as the active ingredient.
Vabysmo side effects
The most common side effects of Vabysmo in clinical trials include:
- Conjunctival hemorrhage
In rare instances, Vabysmo can cause more serious side effects. These can include:
- Endophthalmitis and retinal detachments
- Increases in intraocular pressure
- The potential risk of arterial thromboembolic events (ATEs) associated with VEGF inhibition
- Vitreous floaters
- Eye pain
- Intraocular inflammation
- Eye irritation
- Ocular discomfort
- Retinal pigment epithelial tear (nAMD only)
Your doctor will assess the benefits of using Vabysmo against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Vabysmo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Vabysmo drug interactions
Other drugs may interact with Vabysmo, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medication including any supplements you are taking.
You should not use Vabysmo if you:
- Are allergic to the active ingredient faricimab-svoa
- Are allergic to any of the other ingredients in Vabysmo
- Have an ocular or periocular infection
- Have active intraocular inflammation
Talk to your doctor before using Vabysmo if you:
- Are taking any of the medications that could interact with Vabysmo
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Vabysmo is the trademark brand name for faricimab-svoa manufactured by Genentech a subsidiary of the Roche group. A generic version of faricimab-svoa is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Vabysmo savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.